|
Overview :
Screening to detect heterozygote carriers for a genetic
condition should be done in accordance with specific guidelines. These are
intended to provide optimum care for both affected and unaffected persons.
Guidelines for screening programs:
(1) Screening
should be voluntary.
(2) Testing and
the results must be kept confidential.
(3) Informed
consent is required for testing.
(4) The
screening program must include adequate education and counseling.
(5) The testing
laboratory must participate and perform acceptably in quality control, quality
assurance and proficiency programs.
(6) Access to
testing should be equal for all persons at risk.
|